Trial
NCT00853944
Effect of Sitagliptin on Graft Function Following Islet Transplantation
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of British Columbia
Collaborators
Merck Sharp & Dohme LLC
Condition
Islet Transplantation
Intervention
sitagliptin
Why stopped
Sponsor withdrew funding du to lack of enrollment. Lack of enrollment was due to decrease in number of islet transplant procedures
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-30